CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,049 shares (to pay taxes)
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market sale President & CEO sold 223,100 shares at $2.02 ($449,770)
- 144 Insider Sale of Securities
- 8-K/A Event Exhibits
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Exhibits
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Unregistered share sale
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Acquisition or sale completed · Other events
- 10-Q Report Quarterly Report
Page 10 of 47 · 923 filings